LncRNA H19/miR-29b-3p/PGRN Axis Promoted Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Acting on Wnt Signaling
Overview
Molecular Biology
Affiliations
This investigation was aimed at working out the combined role of lncRNA H19, miR-29b and Wnt signaling in the development of colorectal cancer (CRC). In the aggregate, 185 CRC tissues and corresponding para-carcinoma tissues were gathered. The human CRC cell lines (i.e. HT29, HCT116, SW480 and SW620) and normal colorectal mucosa cell line (NCM460) were also purchased. Si-H19, si-NC, miR-29b-3p mimics, miR-29b-3p inhibitor, si-PGRN and negative control (NC) were, respectively, transfected into the CRC cells. Lucif-erase reporter plasmids were prepared to evaluate the transduction activity of Wnt/β-catenin signaling pathway, and dual-luciferase reporter gene assay was arranged to confirm the targeted relationship between H19 and miR-29b-3p, as well as between miR-29b-3p and PGRN. Finally, the proliferative and invasive capacities of CRC cells were appraised through transwell, MTT and scratch assays. As a result, over-expressed H19 and down-expressed miR-29b-3p displayed close associations with the CRC patients' poor prognosis ( < 0.05). Besides, transfection with si-H19, miR-29b-3p mimic or si-PGRN were correlated with elevated E-cadherin expression, decreased snail and vimentin expressions, as well as less-motivated cell proliferation and cell metastasis ( < 0.05). Moreover, H19 was verified to directly target miR-29b-3p based on the luciferase reporter gene assay ( < 0.05), and miR-29b-3p also bound to PGRN in a direct manner ( < 0.05). Finally, addition of LiCl (Wnt/β-catenin pathway activator) or XAV93920 (Wnt/β-catenin pathway inhibitor) would cause remarkably altered E-cadherin, c-Myc, vimentin and snail expressions, as well as significantly changed transcriptional activity of β-catenin/Tcf reporter plasmid ( < 0.05). In conclusion, the lncRNA H19/miR-29b-3p/PGRN/Wnt axis counted a great deal for seeking appropriate diagnostic biomarkers and treatment targets for CRC.
Role of the lncRNA/Wnt signaling pathway in digestive system cancer: a literature review.
Li P, Ma X, Huang D Eur J Med Res. 2024; 29(1):447.
PMID: 39218950 PMC: 11367813. DOI: 10.1186/s40001-024-02033-w.
Cordaro A, Barreca M, Zichittella C, Loria M, Anello D, Arena G J Exp Clin Cancer Res. 2024; 43(1):217.
PMID: 39098911 PMC: 11299361. DOI: 10.1186/s13046-024-03139-z.
Reciprocal interactions between lncRNAs and MYC in colorectal cancer: partners in crime.
Lei Z, Zhu Z, Yao Z, Dai X, Dong Y, Chen B Cell Death Dis. 2024; 15(7):539.
PMID: 39075086 PMC: 11286766. DOI: 10.1038/s41419-024-06918-w.
Decoding long non‑coding RNAs: Friends and foes in cancer development (Review).
Song H, Adu-Amankwaah J, Zhao Q, Yang D, Liu K, Bushi A Int J Oncol. 2024; 64(6).
PMID: 38695241 PMC: 11095623. DOI: 10.3892/ijo.2024.5649.
Sun J, Du Q, Zhao L, Huang J, Yu H, Ding H Int Urol Nephrol. 2024; 56(8):2779-2791.
PMID: 38530583 DOI: 10.1007/s11255-024-03992-z.